Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minhua Zhou

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Journal of Ethnopharmacology|March 21, 2008
Antinociceptive and anti-inflammatory activities of Aquilaria sinensis (Lour.) Gilg. Leaves extractMinhua Zhou, Honggang Wang, Suolangjiba, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|September 1, 2019
Association of polymorphisms in the MCP-1 and CCR2 genes with the risk of Parkinson's diseaseYan Wang, Minhua Zhou, Yong Wang, et al.
Medicine|November 25, 2020
Correlation between CYP11B2 polymorphism and the risk of preeclampsiaYan Wang, Minhua Zhou, Xun Deng, et al.
Medicine|November 25, 2020
Association of transferrin G258A and transferrin receptor A82G polymorphisms with the risk of Parkinson disease in certain areaYan Wang, Yong Wang, Minhua Zhou, et al.
Molecular Therapy. Nucleic Acids|June 12, 2025
Targeting CIDEB alleviates liver steatosis and fibrosis in mouse MASH modelsYingying Lin, Fushun Fan, Zhenxian Mo, et al.
Bioconjugate Chemistry|June 21, 2025
TfR1-Binding Peptide Conjugation Facilitates Robust and Specific siRNA Delivery to the Central Nervous SystemTiancheng Fu, Fushun Fan, Yingying Lin, et al.
Cancer Research|October 29, 2021
A Dual PI3K/HDAC Inhibitor Induces Immunogenic Ferroptosis to Potentiate Cancer Immune Checkpoint TherapyFushun Fan, Pei Liu, Rudi Bao, et al.
Targeted Oncology|October 19, 2023
Dual PI3K/HDAC Inhibitor BEBT-908 Exhibits Potent Efficacy as Monotherapy for Primary Central Nervous System LymphomaNing Wang, Zhenxian Mo, Lu Pan, et al.
Translational Oncology|December 15, 2020
BEBT-109, a pan-mutant-selective EGFR inhibitor with potent antitumor activity in EGFR-mutant non-small cell lung cancerFushun Fan, Minhua Zhou, Xiaolan Ye, et al.
Journal of Translational Medicine|October 4, 2013
The AKT inhibitor AZD5363 is selectively active in PI3KCA mutant gastric cancer, and sensitizes a patient-derived gastric cancer xenograft model with PTEN loss to TaxotereJing Li, Barry R Davies, Sufang Han, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal of Ethnopharmacology|March 21, 2008
Antinociceptive and anti-inflammatory activities of Aquilaria sinensis (Lour.) Gilg. Leaves extractMinhua Zhou, Honggang Wang, Suolangjiba, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|September 1, 2019
Association of polymorphisms in the MCP-1 and CCR2 genes with the risk of Parkinson's diseaseYan Wang, Minhua Zhou, Yong Wang, et al.
Medicine|November 25, 2020
Correlation between CYP11B2 polymorphism and the risk of preeclampsiaYan Wang, Minhua Zhou, Xun Deng, et al.
Medicine|November 25, 2020
Association of transferrin G258A and transferrin receptor A82G polymorphisms with the risk of Parkinson disease in certain areaYan Wang, Yong Wang, Minhua Zhou, et al.
Molecular Therapy. Nucleic Acids|June 12, 2025
Targeting CIDEB alleviates liver steatosis and fibrosis in mouse MASH modelsYingying Lin, Fushun Fan, Zhenxian Mo, et al.
Bioconjugate Chemistry|June 21, 2025
TfR1-Binding Peptide Conjugation Facilitates Robust and Specific siRNA Delivery to the Central Nervous SystemTiancheng Fu, Fushun Fan, Yingying Lin, et al.
Cancer Research|October 29, 2021
A Dual PI3K/HDAC Inhibitor Induces Immunogenic Ferroptosis to Potentiate Cancer Immune Checkpoint TherapyFushun Fan, Pei Liu, Rudi Bao, et al.
Targeted Oncology|October 19, 2023
Dual PI3K/HDAC Inhibitor BEBT-908 Exhibits Potent Efficacy as Monotherapy for Primary Central Nervous System LymphomaNing Wang, Zhenxian Mo, Lu Pan, et al.
Translational Oncology|December 15, 2020
BEBT-109, a pan-mutant-selective EGFR inhibitor with potent antitumor activity in EGFR-mutant non-small cell lung cancerFushun Fan, Minhua Zhou, Xiaolan Ye, et al.
Journal of Translational Medicine|October 4, 2013
The AKT inhibitor AZD5363 is selectively active in PI3KCA mutant gastric cancer, and sensitizes a patient-derived gastric cancer xenograft model with PTEN loss to TaxotereJing Li, Barry R Davies, Sufang Han, et al.
Pageof 2